Alcohol-related harm in Europe and the WHO policy response

Similar documents
European Status report on Alcohol and Health

European status report on alcohol and health Leadership, awareness and commitment

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

The cancer burden in the European Union and the European Region: the current situation and a way forward

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

WCPT COUNTRY PROFILE December 2017 SERBIA

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Highlighting in the WHO European Region:

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

Q1 What age are you?

Better Health for All in Latvia

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Where we stand in EFORT

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Budapest, Hungary, September 2017 xx July xxx. Progress reports

Summary. Primary care data. Week 49/2014. Season

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Engagement in language assessment / Regions of Europe

Alcohol consumption, harm and policy responses in Europe. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Prevention of Oral Cancer Special Interest Working Group

LEBANON. WCPT COUNTRY PROFILE December 2018

Smokefree Policies in Europe: Are we there yet?

DENMARK. WCPT COUNTRY PROFILE December 2018

European Association of Dental Public Health Prevention of Oral Cancer

Development of Palliative Care services in different countries

GERMANY. WCPT COUNTRY PROFILE December 2018

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Inequality in injury risks

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Welcome to the new EURO Immunization Monitor

Alcohol related harms to children and youth and ways to address it Case of Finland

The challenge of obesity in the WHO European Region

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Overview of drug-induced deaths in Europe - What does the data tell us?

Cardiovascular disease in Europe: epidemiological update 2016

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

Real Life, Real PD Survey

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Overall survival: 1 st line therapy

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Underage drinking in Europe

Monthly measles and rubella monitoring report

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Cross Border Genetic Testing for Rare Diseases

Positioning health equity and the social determinants of health on the regional development agenda Investment for health and development in Slovenia

Cannabis policies & cannabis use

State of Health In EU: Community Pharmacy Contribution

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Table 7.1 Summary information for lung cancer in Ireland,

World Health Organization Regional Office for Europe THE EUROPEAN REPORT ON TOBACCO CONTROL POLICY

Table 6.1 Summary information for colorectal cancer in Ireland,

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

Where do EU Contries set the limit for low risk drinking.

SVERIGES DÖVAS UNGDOMSFÖRBUND (SDUF), SWEDISH YNAD

European Report on Alcohol Policy

Alcohol Prevention Day

Access to treatment and disease burden

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Table 9.1 Summary information for stomach cancer in Ireland,

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

European Collaboration on Dementia. Luxembourg, 13 December 2006

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

Injuries in Europe: a call for public health action An update from 2008 WHO Global Burden of Disease

11 Melanoma of the skin

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

A report on the epidemiology of selected vaccine-preventable diseases in the European Region

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Comparative analysis of nutrition policies in the WHO European Region

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Best practices in collecting and processing data in CRC screening and after it

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

Tenth meeting of the European Technical Advisory Group of Experts on Immunization: Outcomes and recommendations

Perspectives for information on alcohol use in the EU

Access to HCV treatment in Europe

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Transcription:

Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation

NCD global monitoring framework: alcohol-related targets and indicators One target: At least 1% relative reduction in the harmful use of alcohol, as appropriate, within the national context. Indicators: Total (recorded and unrecorded) alcohol per capita (15+ years old) consumption Age-standardized prevalence of heavy episodic drinking Alcohol-related morbidity and mortality Alcohol Date and of harm presentation

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol Alcohol and harm Date of presentation

SDG 215: 17 goals (1 health), 169 targets (13 health) adopted at the United Nations Sustainable Development Summit 215 25 27 September 215 3.5.1 Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders 3.5.2 Harmful use of alcohol, defined according to the national context as alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol 3.5.3 Past 12 month prevalence of alcohol and drug use (still under negotiation) Alcohol Date and of harm presentation

New data Alcohol and harm Date of presentation

Alcohol Date and of harm presentation

Total average alcohol per capita consumption, recorded and unrecorded, 214, men and women 2 18 16 14 12 1 8 6 4 2 Litres of pure alcohol Turkey Tajikistan Azerbaijan FYR Macedonia Israel Turkmenistan Uzbekistan Kyrgyzstan Armenia Bosnia Herzegovina Albania Italy Iceland Georgia Norway Malte Kazakhstan Greece Sweden Netherlands Europe Switzerland Spain Denmark Ireland Finland Andorra Slovenia Serbia Portugal Luxembourg Germany Montenegro France Great Britain Austria Cyprus Slovakia Latvia Croatia Hungary Poland Belgium Bulgaria Ukraine Estonia Czech Republic Romania Russian Federation Republic of Moldova Belarus Lithuania

Alcohol use during the past 3 days, boys (ESPAD, 215) % 8 7 6 5 4 3 2 1 Alcohol Date and of harm presentation

Alcohol use during the past 3 days, girls (ESPAD, 215) % 8 7 6 5 4 3 2 1 Alcohol Date and of harm presentation

Being drunk during the past 3 days, boys (ESPAD, 215) % 35 3 25 2 15 1 5 Alcohol Date and of harm presentation

Being drunk during the past 3 days, girls (ESPAD, 215) % 35 3 25 2 15 1 5 Alcohol Date and of harm presentation

Age standardized alcohol-attributable mortality, 214 (rate per million) 2 18 16 14 12 1 8 6 4 2 Alcohol and harm Date of presentation

3 25 2 15 1 5 Alcohol attributable liver cirrhosis mortality. Rates per million Kyrgyzstan Republic of Moldova Kazakhstan Uzbekistan Romania Hungary Turkmenistan Lithuania Slovakia Ukraine Georgia Belarus Slovenia Croatia Russian Federation Azerbaijan Poland Armenia Bulgaria Tajikistan Estonia Czech Republic Finland Latvia Portugal Denmark Austria Germany France Belgium United Kingdom Spain Italy Serbia Bosnia and Herzegovina Ireland Switzerland Montenegro Sweden Netherlands Greece Malta The former Yugoslav Republic of Cyprus Norway Israel Turkey Iceland Albania

14 12 1 8 6 4 2 2 Alcohol attributable CVD mortality. Rates per million Belarus Ukraine Republic of Moldova Russian Federation Kyrgyzstan Kazakhstan Bulgaria Montenegro Turkmenistan Georgia Uzbekistan Tajikistan Romania Lithuania Poland Serbia Estonia Azerbaijan Bosnia and Herzegovina Armenia Portugal Albania Slovakia Greece Malta Turkey Ireland Croatia Hungary Spain Slovenia The former Yugoslav Republic of Cyprus France Sweden Italy Germany Austria United Kingdom Belgium Netherlands Israel Denmark Czech Republic Finland Latvia Switzerland Iceland Norway

Alcohol attributable cancer mortality. Rates per million 14 12 1 8 6 4 2 Hungary Slovakia Belarus Lithuania Croatia Kazakhstan Czech Republic Romania Republic of Moldova Ukraine Poland France Estonia Russian Federation Bulgaria Slovenia Portugal Serbia Latvia Turkmenistan Belgium Germany United Kingdom Netherlands Spain Denmark Montenegro Ireland Austria Georgia Switzerland Italy Armenia Bosnia and Finland Greece Kyrgyzstan Sweden Malta Uzbekistan Norway The former Yugoslav Albania Cyprus Azerbaijan Iceland Israel Tajikistan Turkey

7 6 5 4 3 2 1 Alcohol attributable injury mortality. Rates per million Belarus Russian Federation Ukraine Lithuania Kazakhstan Republic of Moldova Estonia Latvia Poland Romania Georgia Hungary Slovenia Slovakia Belgium France Czech Republic Turkmenistan Finland Kyrgyzstan Armenia Austria Bulgaria Croatia Germany Uzbekistan Montenegro Ireland Greece Sweden Denmark Portugal Spain Iceland United Kingdom Norway Netherlands Switzerland Italy Albania Cyprus Azerbaijan Malta Bosnia and Herzegovina Serbia Israel The former Yugoslav Republic of Tajikistan Turkey

The WHO Policy Response Alcohol Date and of harm presentation

Global strategy and European action plan Alcohol Date and of harm presentation

European action plan to reduce the harmful use of alcohol (EAAP) 212 22 1 action areas Leadership, awareness and commitment, as sustainable intersectoral action requires strong leadership and a solid base of awareness and political will Health services response, as these services are central to tackling health conditions in individuals caused by harmful alcohol use Community action, as governments and other stakeholders can support and empower communities in adopting effective approaches to prevent and reduce harmful alcohol use Policies and countermeasures on drink driving, as it is extremely dangerous to drivers, passengers and other people using the roads Availability of alcohol, as public health policies to regulate commercial or public availability have proved to be very effective in reducing the general level of harmful use and drinking among minors Alcohol Date and of harm presentation

EAAP 212 22 1 action areas Marketing of alcoholic beverages, as systems are needed to protect people, particularly children and young people, from advanced advertising and promotion techniques Pricing policies, as most consumers, particularly heavy drinkers and young people, are sensitive to changes in the prices of alcohol products Reducing the negative consequences of drinking and alcohol intoxication, in order to minimize violence, intoxication and harm to intoxicated people Reducing the public health impact of illicit and informally produced alcohol, as its consumption could have additional negative health consequences due to its higher ethanol content and potential contamination with toxic substances Monitoring and surveillance, as relevant data create the basis for the appropriate delivery and success of responses Alcohol Date and of harm presentation

Alcohol policy scoring Strengths The role of governments in reducing population exposure to modifiable risk factors is emphasized. Political accountability is promoted. A rounded evaluation of national alcohol strategies is provided. A big picture for each overarching policy area is presented. Comparisons between countries are facilitated. Monitoring of a country s progress over time is facilitated. Communication with stakeholders is simplified. Limitations Enforcement of policies is not measured. Some aspects of the methodology (such as policy weights) are potentially contentious. Data for some indicators (such as pricing estimates) are less reliable. Aggregated information does not reflect subnational variations in alcohol policies. Summary measures are prone to being misinterpreted. Alcohol and harm Date of presentation

Leadership, awareness and commitment (n=29) 1 9 8 7 6 Score 5 4 3 2 1

Health services response (n=18) 1 9 8 7 6 Score 5 4 3 2 1

Community and workplace action (n=29) 1 9 8 7 6 Score 5 4 3 2 1

Drink driving policies and countermeasures (n=3) 1 9 8 7 6 Score 5 4 3 2 1

Availability of alcohol (n=3) 1 9 8 7 6 Score 5 4 3 2 1

Marketing of alcoholic beverages (n=3) 1 9 8 7 6 Score 5 4 3 2 1

Pricing policies (n=27) 1 9 8 7 6 Score 5 4 3 2 1

Reducing the negative consequences of drinking and alcohol intoxication (n=31) 1 9 8 7 6 Score 5 4 3 2 1

Reducing the public health impact of illicit alcohol and informally produced alcohol (n=53) 1 9 8 7 6 Score 5 4 3 2 1

Monitoring and surveillance (n=3) 1 9 8 7 6 Score 5 4 3 2 1

Our publications Alcohol and harm Date of presentation

More information on the WHO website mollerl@who.int http://www.euro.who.int/alcohol Alcohol and harm Date of presentation